February 5, 2024 07:11 AM EST
R&D

Am­gen en­ters weight loss mar­ket with drug that shows 14.5% weight re­duc­tion

Katherine Lewin

News Reporter

Ear­ly da­ta of Am­gen’s weight loss drug Mar­i­Tide showed com­pa­ra­ble weight loss to pop­u­lar drugs on the mar­ket and in de­vel­op­ment, with pa­tients on the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times